Analyst price target range
Crescent Biopharma Price Target: $30.60 Average
Direct answer
Crescent Biopharma's average price target is $30.60.
The verified analyst range runs from $27.00 to $35.00.
The low target implies +28.6%, the high target implies +66.7%, and the range spans 38.1% of the current price.
Forecast evidence checked September 8, 2026.
Get free Crescent Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $20.99
- Average price target
- $30.60
- High price target
- $35.00
- Low price target
- $27.00
- Low target gap
- +28.6%
- Target upside
- +45.8%
- High target gap
- +66.7%
- Target range width
- 38.1%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- September 8, 2026
- Valid through
- September 15, 2026
Explore related company data
Read the frequently asked questions.
What is Crescent Biopharma's average price target?
Crescent Biopharma's verified average price target is $30.60. The target range is $27.00 to $35.00.
How far are Crescent Biopharma's low and high targets from the recorded price?
The low target implies +28.6%, while the high target implies +66.7%.
How many analysts are included in Crescent Biopharma's consensus?
The verified consensus includes 5 analysts.
How is Crescent Biopharma's target upside or downside calculated?
The average target of $30.60 is divided by the recorded price of $20.99, then one is subtracted to produce +45.8%. This does not guarantee a future return.
When was Crescent Biopharma's analyst forecast verified?
The data was verified on 2026-09-08. The dataset is valid through 2026-09-15.